Goldman Sachs’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Goldman Sachs’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-119,800	Closed	-$2.51M	–	5848
2018 Q2	$2.51M	Buy	119,800 +19,800	+20%	+$367K	﹤0.01%	3483
2018 Q1	$1.61M	Buy	+100,000	New	+$1.98M	﹤0.01%	3743
2015 Q3	–	Sell	-72,600	Closed	-$497K	–	7542
2015 Q2	$497K	Sell	72,600 -59,100	-45%	-$375K	﹤0.01%	5224
2015 Q1	$799K	Buy	+131,700	New	+$876K	﹤0.01%	4677

Goldman Sachs's SPPI Position: Q3 2023 in Review

Goldman Sachs sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 19,106 shares — an estimated $18.3K sold.

Goldman Sachs first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $35.2M in Q4 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

Goldman Sachs reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
Goldman Sachs sold 19,106 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $18.3K.
Goldman Sachs first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
Goldman Sachs's Spectrum Pharmaceuticals Inc position peaked at $35.2M in Q4 2017.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.